After announcing it will not dispense an abortion pill in 21 states where Republican attorneys general have threatened legal action against pharmacies distributing the medicine, Walgreens (WBA) has landed in the center of a consumer and political controversy, Pam Belluck and Julie Creswell of The New York Times reports. Late last week, Walgreens confirmed it would not distribute mifepristone, the first pill in a two-drug medication abortion regimen, after it and other large pharmacy chains received signed letters by those attorney generals. A spokesman for Walgreens said the chain had always dispensed the drug where state laws allowed pharmacists to do so and had decided that it would face legal repercussions in those 21 states before its received the letters from the attorney generals. CVS (CVS) and Rite Aid (RAD) also face the same legal and reputational dilemma as Walgreens. Reference Link
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on WBA:
- Walgreens (WBA) Snagged in Political Drama Over Abortion Pill
- Walgreens Boots Alliance to dispense Mifepristone where ‘legally permissible’
- California ‘done’ with Walgreens over abortion pill stance
- Walgreens will not distribute abortion pills in 20 states, Reuters report
- Walgreens with DoorDash, Uber announce free Same Day Rx Delivery for HIV